In the last 5 years
Delivering new insights to drive personalized trials
신장학
Collaborate with a board-certified nephrologist (who is also in academia), to ensure successful trial design and execution
Engage Fortrea’s regulatory strategy and operational experts for data-driven planning
Leverage relationships with nephrology sites and trial stakeholders (such as Dialysis Organizations and Kidney Patient Advocacy Groups) to deliver timely diversity-focused recruitment
Experience matters when choosing a partner
178
Nephrology Studies
5,000+
Sites
23,000명+
환자
Top Indications
-
Dialysis and End Stage Kidney Disease (ESKD)
-
Glomerular Disease
-
Chronic Kidney Disease (CKD) and its complications
-
Pediatric CDK and ESKD
-
Renal Impairment Studies
Get the latest from Fortrea
We’re sharing our latest news, events, and publications
Get to know us
Barbara S. Gillespie, MD, MMS, FASN
Vice President & Therapeutic Strategy Leader
약력 보기
Your agile partner for comprehensive nephrology clinical trials
We bring extensive depth of expertise to nephrology therapeutic development. Once your trial is underway, you can rely on Fortrea’s clinical trial management team to provide close communication and collaboration. We use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.
1상에서 4상까지 아우르는 포괄적인 임상 실험 관리, 임상 약학, 환자 액세스 솔루션 및 기타 지원 서비스를 제공하는 Fortrea는 신흥·대형 바이오 제약회사, 의료 기기 및 진단 기업과 협력하고 있습니다.
귀사의 니즈. 당사의 솔루션
1상에서 4상까지 아우르는 포괄적인 임상 실험 관리, 임상 약학, 환자 액세스 솔루션 및 기타 지원 서비스를 제공하는 Fortrea는 신흥·대형 바이오 제약회사, 의료 기기 및 진단 기업과 협력하고 있습니다.